Avicanna board member Eileen McCormack resigns ahead of May 7 shareholders meeting

Avicanna Inc., a biopharmaceutical company specializing in cannabinoid-based products, announced that board member Eileen McCormack has resigned effective May 1, 2026, before the upcoming annual general and special shareholders meeting on May 7. McCormack was not up for re-election at this meeting. Avicanna continues to focus on its development and commercialization of medical cannabis and pharmaceutical products globally, with multiple business pillars including medical cannabis formularies, patient care platforms, pharmaceutical pipelines, and active pharmaceutical ingredients. This board change is part of the company’s ongoing governance updates as it advances its strategic goals in the cannabinoid market.